Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Frauke Muecksch

Showing results (1-10 of 70) with videos related to

Pageof 7
Sort By:
Journal of Virology|August 13, 2024
Probing Gag-Env dynamics at HIV-1 assembly sites using live-cell microscopyFrauke Muecksch, Severina Klaus, Vibor Laketa, et al.
Biorxiv : the Preprint Server for Biology|September 2, 2022
Antigen presentation dynamics shape the response to emergent variants like SARS-CoV-2 Omicron strain after multiple vaccinations with wild type strainLeerang Yang, Matthew Van Beek, Zijun Wang, et al.
Cell Reports|March 23, 2023
Antigen presentation dynamics shape the antibody response to variants like SARS-CoV-2 Omicron after multiple vaccinations with the original strainLeerang Yang, Matthew Van Beek, Zijun Wang, et al.
Mbio|January 9, 2024
SARS-CoV-2 spike glycosylation affects function and neutralization sensitivityFengwen Zhang, Fabian Schmidt, Frauke Muecksch, et al.
Biorxiv : the Preprint Server for Biology|July 10, 2023
SARS-CoV-2 spike glycosylation affects function and neutralization sensitivityFengwen Zhang, Fabian Schmidt, Frauke Muecksch, et al.
Cell Host & Microbe|August 13, 2021
HIV-1 matrix-tRNA complex structure reveals basis for host control of Gag localizationCharles Bou-Nader, Frauke Muecksch, Janae B Brown, et al.
Biorxiv : the Preprint Server for Biology|January 5, 2021
"A recombinant protein SARS-CoV-2 candidate vaccine elicits high-titer neutralizing antibodies in macaques."Gary Baisa, David Rancour, Keith Mansfield, et al.
Research Square|January 14, 2021
A Recombinant Protein SARS-CoV-2 Candidate Vaccine Elicits High-titer Neutralizing Antibodies in MacaquesGary Baisa, David Rancour, Keith Mansfield, et al.
Medrxiv : the Preprint Server for Health Sciences|December 21, 2021
Plasma neutralization properties of the SARS-CoV-2 Omicron variantFabian Schmidt, Frauke Muecksch, Yiska Weisblum, et al.
Transfusion|January 15, 2021
Neutralizing activity to SARS-CoV-2 of convalescent and control plasma used in a randomized controlled trialAlex T Freedenberg, Chun-Hao Pan, William E Diehl, et al.
Pageof 7

Showing results (1-10 of 70) with videos related to

Sort By:
Pageof 7
Journal of Virology|August 13, 2024
Probing Gag-Env dynamics at HIV-1 assembly sites using live-cell microscopyFrauke Muecksch, Severina Klaus, Vibor Laketa, et al.
Biorxiv : the Preprint Server for Biology|September 2, 2022
Antigen presentation dynamics shape the response to emergent variants like SARS-CoV-2 Omicron strain after multiple vaccinations with wild type strainLeerang Yang, Matthew Van Beek, Zijun Wang, et al.
Cell Reports|March 23, 2023
Antigen presentation dynamics shape the antibody response to variants like SARS-CoV-2 Omicron after multiple vaccinations with the original strainLeerang Yang, Matthew Van Beek, Zijun Wang, et al.
Mbio|January 9, 2024
SARS-CoV-2 spike glycosylation affects function and neutralization sensitivityFengwen Zhang, Fabian Schmidt, Frauke Muecksch, et al.
Biorxiv : the Preprint Server for Biology|July 10, 2023
SARS-CoV-2 spike glycosylation affects function and neutralization sensitivityFengwen Zhang, Fabian Schmidt, Frauke Muecksch, et al.
Cell Host & Microbe|August 13, 2021
HIV-1 matrix-tRNA complex structure reveals basis for host control of Gag localizationCharles Bou-Nader, Frauke Muecksch, Janae B Brown, et al.
Biorxiv : the Preprint Server for Biology|January 5, 2021
"A recombinant protein SARS-CoV-2 candidate vaccine elicits high-titer neutralizing antibodies in macaques."Gary Baisa, David Rancour, Keith Mansfield, et al.
Research Square|January 14, 2021
A Recombinant Protein SARS-CoV-2 Candidate Vaccine Elicits High-titer Neutralizing Antibodies in MacaquesGary Baisa, David Rancour, Keith Mansfield, et al.
Medrxiv : the Preprint Server for Health Sciences|December 21, 2021
Plasma neutralization properties of the SARS-CoV-2 Omicron variantFabian Schmidt, Frauke Muecksch, Yiska Weisblum, et al.
Transfusion|January 15, 2021
Neutralizing activity to SARS-CoV-2 of convalescent and control plasma used in a randomized controlled trialAlex T Freedenberg, Chun-Hao Pan, William E Diehl, et al.
Pageof 7